Skip to content

A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent

A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent: Prospective Randomized Multicenter Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05220475
Enrollment
108
Registered
2022-02-02
Start date
2021-10-25
Completion date
2024-10-24
Last updated
2022-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Biliary Obstruction

Keywords

Fully Covered Self Expandable Metal Stent, Uncovered Self Expandable Metal Stent

Brief summary

Multi-center, randomized controlled study fc-SEMS with anchoring plastic stent vs uc-SEMS in malignant biliary obstruction

Detailed description

This study is multi-center, randomized controlled study to compare the stent patency in malignant biliary obstruction. The patency of fully covered self expandable metal stent with external anchoring plastic stent was compared with that of uncovered self expandable metal stent.

Interventions

DEVICEfully covered self-expandable metal stent with an anchoring external plastic stent

Extrahepatic malignant biliary obstruction treated with fully covered self-expandable metal stent with an anchoring plastic stent

DEVICEuncovered self-expandable metal stent

Extrahepatic malignant biliary obstruction treated with uncovered self-expandable metal stent without an anchoring plastic stent

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults with 19 years of age or older * Those who voluntarily consented to the trial and signed a written consent * Inoperable malignant biliary obstruction

Exclusion criteria

* Previous surgical biliary drainage * Patients continuosly requiring percutaneous transhepatic biliary drainage * History of biliary drainage with metal stent * Biliary obstruction located in hilum or intrahepatic duct * Patients with life expectancy of 3 months or less * On pregnancy * Unable to underwent endoscopic procedures

Design outcomes

Primary

MeasureTime frameDescription
Rate of patent stent1 yearThe number of patient without stent dysfuction divided by total number of patients

Secondary

MeasureTime frameDescription
Stent obstruction1 yearSuspected by jaundice (Total bilirubin \> 2 upper normal limit) or radiologic finding of stent occlusion which is confirmed by ERCP
Stent migration1 yearRadiologic finding of migration through Abdomen X-ray or CT scan
Re-intervention1 yearEndoscopic retrograde biliary drainage or Percutaneous transhepatic biliary drainage
Adverse event1 yearacute cholangitis, acute cholecystitis, acute pancreatitis
Overall survival1 yearTimespan from the diagnosis to the death

Countries

South Korea

Contacts

Primary ContactSang Hyub Lee, MD, PhD
gidoctor@snu.ac.kr82-2072-2228

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026